Seeing Is Believing
Currently out of the existing stock ratings of Craig Bijou, 41 are a BUY (67.21%), 13 are a HOLD (21.31%), 7 are a SELL (11.48%).
Analyst Craig Bijou, currently employed at BAML, carries an average stock price target met ratio of 69.11% that have a potential upside of 25.31% achieved within 197 days.
Craig Bijou’s has documented 125 price targets and ratings displayed on 16 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on BLCO, Bausch + Lomb Corp at 12-Dec-2024.
Analyst best performing recommendations are on RMED (RA MEDICAL SYSTEMS).
The best stock recommendation documented was for RMED (RA MEDICAL SYSTEMS) at 8/13/2019. The price target of $2500 was fulfilled within 7 days with a profit of $987.5 (65.29%) receiving and performance score of 93.27.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$640
$100.42 (18.61%)
$560
9 days ago
(11-Dec-2024)
15/17 (88.24%)
$93.36 (17.08%)
303
Buy
$610
$70.42 (13.05%)
$525
15 days ago
(05-Dec-2024)
27/28 (96.43%)
$62.82 (11.48%)
216
Buy
$561
$21.42 (3.97%)
$535
24 days ago
(26-Nov-2024)
16/17 (94.12%)
$19.77 (3.65%)
177
Buy
$565
$25.42 (4.71%)
$440
2 months 2 days ago
(18-Oct-2024)
3/4 (75%)
$43.85 (8.41%)
137
Buy
$538
$-1.58 (-0.29%)
$495
2 months 2 days ago
(18-Oct-2024)
29/29 (100%)
$16.85 (3.23%)
152
Which stock is Craig Bijou is most bullish on?
Which stock is Craig Bijou is most reserved on?
What Year was the first public recommendation made by Craig Bijou?